Clinical • PD(L)-1 Biomarker • Metastases
|
FGFR3 (Fibroblast growth factor receptor 3) • TACC3 (Transforming acidic coiled-coil containing protein 3)
|
FGFR3-TACC3 fusion
|
Guardant360® CDx • ACTOnco
|
Keytruda (pembrolizumab) • Opdivo (nivolumab) • cisplatin • Imfinzi (durvalumab) • gemcitabine • sorafenib • Lenvima (lenvatinib) • Balversa (erdafitinib) • Cyramza (ramucirumab) • Padcev (enfortumab vedotin-ejfv)